Verrica Pharmaceuticals Inc (VRCA)
0.8633
+0.02
(+2.11%)
USD |
NASDAQ |
Nov 14, 16:00
0.8732
+0.01
(+1.15%)
After-Hours: 20:00
Verrica Pharmaceuticals Free Cash Flow (Quarterly): -8.574M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.574M |
| June 30, 2024 | -16.37M |
| March 31, 2024 | -19.95M |
| December 31, 2023 | -14.73M |
| September 30, 2023 | -14.88M |
| June 30, 2023 | -4.728M |
| March 31, 2023 | -4.601M |
| December 31, 2022 | -5.02M |
| September 30, 2022 | 1.748M |
| June 30, 2022 | -7.335M |
| March 31, 2022 | -8.345M |
| December 31, 2021 | -8.935M |
| September 30, 2021 | -10.64M |
| June 30, 2021 | 2.203M |
| March 31, 2021 | -11.10M |
| December 31, 2020 | -6.643M |
| Date | Value |
|---|---|
| September 30, 2020 | -7.719M |
| June 30, 2020 | -8.71M |
| March 31, 2020 | -8.605M |
| December 31, 2019 | -8.216M |
| September 30, 2019 | -7.907M |
| June 30, 2019 | -5.05M |
| March 31, 2019 | -6.917M |
| December 31, 2018 | -7.553M |
| September 30, 2018 | -5.15M |
| June 30, 2018 | -3.774M |
| March 31, 2018 | -2.171M |
| December 31, 2017 | -1.847M |
| September 30, 2017 | -1.075M |
| June 30, 2017 | -1.152M |
| March 31, 2017 | -0.509M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.95M
Minimum
Mar 2024
2.203M
Maximum
Jun 2021
-8.557M
Average
-8.460M
Median
Free Cash Flow (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 200.30M |
| Elite Pharmaceuticals Inc | 1.466M |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | -9.105M |
| Terns Pharmaceuticals Inc | -16.19M |